NPPB and lung cancer: For the lung cancer endpoint, NT-proBNP remained statistically significant in both models (HR: 1.28; 95% CI: 1.02-1.60; P = 0.030; HR: 1.31; 95% CI: 1.03-1.65; P = 0.025, respectively), while hs-cTnT was not significant in either.